Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, expanded its product portfolio developed for the needs of the single-use bioprocess industry. With the new addition, Qosina now offers a comprehensive selection of components for the design, development and manufacture of single-use systems (SUS).
Scott Herskovitz, President and CEO, Qosina, said: “Qosina has been a trusted supplier for over 40 years and has worked with some of the best-known brands. Our experience serving the needs of regulated customers positions us well to expand our products and services for the single-use bioprocess community. We have leveraged this experience and our extensive supply chain to provide a much-needed resource for bioprocess, vaccine production, and cell and gene therapy.”
Qosina is a one-stop source for single-use bioprocess components, with low minimum order quantities, a liberal sampling policy and a bill of material kitting, all supported by regulatory documentation and backed by Qosina’s assurance of supply.